Re-inventing tumor targeting
Thermosome is a drug development company focused on targeted tumor therapy combined with immune stimulation for improved cancer therapy. At its core is a new tumor targeting concept, which allows for increased local drug concentrations to achieve improved clinical treatment efficacy.
Latest news
Thermosome Establishes High-Profile Clinical Advisory Board
Thermosome Announces Participation in IMAGIO Consortium to Improve Cancer Treatment
Upcoming event
23rd Annual Biotech in Europe Forum
September 20-21, 2023
Basel, Switzerland
